Risultati per: Centri di riferimento HCV - VENETO

Parte in tutta Italia la campagna ‘A casa mi testo’

L’80% delle pazienti seguite da Breast Unit

Aperta la 4 giorni su tecnologie, innovazione e IA per la salute

Al ministero della Salute, coordinata da Sergio Alfieri

Utilizzerà la teleriabilitazione e l’auto-monitoraggio

Utilizzerà la teleriabilitazione e l’auto-monitoraggio

Comunicato del 20/03/2024 n°16

Annuario Figoc, aumentati del 23%. Aiom, solo il 20% degli studi sulle nuove molecole è no profit

Introduction
Many rural communities bear a disproportionate share of drug-related harms. Innovative harm reduction service models, such as vending machines or kiosks, can expand access to services that reduce drug-related harms. However, few kiosks operate in the USA, and their implementation, impact and cost-effectiveness have not been adequately evaluated in rural settings. This paper describes the Kentucky Outreach Service Kiosk (KyOSK) Study protocol to test the effectiveness, implementation outcomes and cost-effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis C and overdose risk in rural Appalachia.

Methods and analysis
KyOSK is a community-level, controlled quasi-experimental, non-randomised trial. KyOSK involves two cohorts of people who use drugs, one in an intervention county (n=425) and one in a control county (n=325). People who are 18 years or older, are community-dwelling residents in the target counties and have used drugs to get high in the past 6 months are eligible. The trial compares the effectiveness of a fixed-site, staffed syringe service programme (standard of care) with the standard of care supplemented with a kiosk. The kiosk will contain various harm reduction supplies accessible to participants upon valid code entry, allowing dispensing data to be linked to participant survey data. The kiosk will include a call-back feature that allows participants to select needed services and receive linkage-to-care services from a peer recovery coach. The cohorts complete follow-up surveys every 6 months for 36 months (three preceding kiosk implementation and four post-implementation). The study will test the effectiveness of the kiosk on reducing risk behaviours associated with overdose, HIV and hepatitis C, as well as implementation outcomes and cost-effectiveness.

Ethics and dissemination
The University of Kentucky Institutional Review Board approved the protocol. Results will be disseminated in academic conferences and peer-reviewed journals, online and print media, and community meetings.

Trial registration number
NCT05657106.

‘Rete nazionale e telemedicina per ridurre migrazione sanitaria’

Primi dati del 2022 del ministero della Salute. Bene anche E-R e Toscana

La situazione che emerge dal monitoraggio del ministero della Salute sembra segnare un peggioramento rispetto all’anno precedente